Login to Your Account



Eyetech, Pfizer Put Macugen Rolling NDA In FDA's Hands

By Aaron Lorenzo


Friday, June 18, 2004
The regulatory process for much-ballyhooed Macugen is under way. Partners Eyetech Pharmaceuticals Inc. and Pfizer Inc. completed their submission of a new drug application with the FDA, applying for use of the potential blockbuster in wet age-related macular degeneration. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription